These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 34184311)
1. Gender disparities in isotretinoin prescribing patterns for pediatric patients before and during practice changes introduced by the COVID-19 pandemic. Tan AJ; Xia J; Herringshaw E; Mayur O; Iqbal A; Cucka B; Biglione B; Locascio JJ; Kroshinsky D Pediatr Dermatol; 2023; 40(5):869-872. PubMed ID: 37495565 [TBL] [Abstract][Full Text] [Related]
3. Readability of iPledge materials for isotretinoin education in English and Spanish. DeMeo D; Reddy HA; Cowden MP; Maytin AK; Carroll BT Arch Dermatol Res; 2023 Sep; 315(7):2175-2178. PubMed ID: 36918437 [TBL] [Abstract][Full Text] [Related]
4. Falsification of at-home isotretinoin pregnancy testing during the COVID-19 pandemic: A case series and proposal of mitigation strategies. Johnson H; Ranum A; Mansh M; Farah RS; Pearson DR JAAD Case Rep; 2022 Oct; 28():49-53. PubMed ID: 35971550 [No Abstract] [Full Text] [Related]
5. The Importance of Gender-Neutral Terminology in Risk Evaluation and Mitigation Strategy Programs: A Call to Action. Burnette C; Smithy W; Strock D; Sivesind TE; Dellavalle R JMIR Dermatol; 2023 Jun; 6():e45329. PubMed ID: 37632908 [TBL] [Abstract][Full Text] [Related]
6. Home pregnancy tests for iPLEDGE: ethically dealing with potential falsifications. Schwartzman G; Flowers H; Grant-Kels JM Int J Womens Dermatol; 2023 Oct; 9(3):e093. PubMed ID: 37440791 [No Abstract] [Full Text] [Related]
7. Ignoring the elephant in the room-overregulated isotretinoin and unregulated dietary supplements in the United States. Zamil DH; Paidisetty PS; Wang LK Proc (Bayl Univ Med Cent); 2022; 35(6):892-893. PubMed ID: 36304632 [TBL] [Abstract][Full Text] [Related]
8. Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era. Charrow A; Xia FD; Lu J; Waul M; Joyce C; Mostaghimi A PLoS One; 2019; 14(3):e0210445. PubMed ID: 30913210 [TBL] [Abstract][Full Text] [Related]
9. Contraceptive counseling for iPLEDGE and its burden on dermatologists. Owens KE; Jiang SW; Nicholas MW Arch Dermatol Res; 2024 May; 316(6):287. PubMed ID: 38805059 [TBL] [Abstract][Full Text] [Related]
11. The future of iPLEDGE: We pledge for more inclusive access to isotretinoin. Shah N; Kirkorian AY Pediatr Dermatol; 2021 Nov; 38 Suppl 2():183-184. PubMed ID: 34184311 [No Abstract] [Full Text] [Related]
12. Prescribing isotretinoin for transgender youth: A pledge for more inclusive care. Boos MD; Ginsberg BA; Peebles JK Pediatr Dermatol; 2019 Jan; 36(1):169-171. PubMed ID: 30318854 [TBL] [Abstract][Full Text] [Related]
13. Administrative Burden of iPLEDGE Deters Isotretinoin Prescriptions: Results From a Survey of Dermatologists. Lee G; Wolf JR; Somers KE Cutis; 2022 Jul; 110(1):44-47. PubMed ID: 36179224 [TBL] [Abstract][Full Text] [Related]